Home > Insider Trading > Filing (0001209191-20-002077)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1016169	Antares Pharma Inc.	ATRS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
901056	Marvin Samson	C/O Antares Pharma, Inc. 100 Princeton South, Suite 300 Ewing NJ 08628		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-01-02	50,000	$2.18	101,751	No	4	M	Direct
Common Stock	Disposition	2020-01-02	50,000	$4.59	51,751	No	4	S	Direct
Common Stock	Acquisiton	2020-01-02	49,395	$2.18	101,146	No	4	M	Direct
Common Stock	Disposition	2020-01-02	49,395	$4.60	51,751	No	4	S	Direct
Common Stock	Acquisiton	2020-01-02	549	$2.66	52,300	No	4	M	Direct
Common Stock	Disposition	2020-01-02	549	$4.60	51,751	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-01-02	99,395	$0.00	99,395	$2.18
Common Stock	Stock Option (right to buy)	Disposition	2020-01-02	549	$0.00	549	$2.66

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2016-05-28	2025-05-27	No	4	M	Direct
0	2018-06-07	2027-06-06	No	4	M	Direct

Footnotes

The stock option exercises and sales of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established in connection with estate planning.
The options vested and became excercisable in four quarterly installments over the one-year period following the grant date of May 28, 2015.
The options vested and became exercisable in four quarterly installments over the one-year period following the grant date of June 7, 2017.